hero section gradient
17 handpicked stocks

U.S. Energy's Great Gas Pivot

U.S. energy companies are cutting oil rigs while increasing natural gas drilling, signaling a key strategic shift in the sector. This pivot creates an investment opportunity in natural gas producers and the service companies that enable more efficient drilling.

Author avatar

Han Tan | Market Analyst

Published on July 26

Your Basket's Financial Footprint

Summary of the basket's total market capitalisation and the concentration of large-cap constituents.

Key Takeaways for Investors:
  • Large-cap concentration generally implies lower volatility and closer tracking of the broader energy market.
  • Suitable as a core holding for energy exposure, not as a high-risk speculative position.
  • Expect steady, long-term value growth rather than short-term explosive gains.
Total Market Cap
  • BKR: $46.09B

  • NGS: $341.78M

  • USEG: $40.49M

  • Other

About This Group of Stocks

1

Our Expert Thinking

U.S. energy companies are making a strategic shift away from oil drilling toward natural gas production. This pivot is driven by volatile oil markets and more stable natural gas fundamentals, creating opportunities for companies positioned to benefit from this capital reallocation across the energy sector.

2

What You Need to Know

This group includes both major natural gas producers leading the charge and essential service companies that provide the specialized equipment and infrastructure needed for efficient gas exploration. The shift represents a significant change in how energy companies are deploying their capital and resources.

3

Why These Stocks

These companies were handpicked by professional analysts based on their strategic positioning in the natural gas pivot. They include firms with expertise in gas exploration, production efficiency, pipeline transport, and the specialized services that enable this industry transformation.

Why You'll Want to Watch These Stocks

🔄

Industry Transformation Underway

A major strategic shift is happening right now as energy companies pivot from oil to natural gas drilling. This kind of sector-wide transformation often creates significant opportunities for investors who position themselves early.

📈

Capital Flowing to Gas

With oil rigs at multi-year lows and gas rigs surging to nearly two-year highs, billions in capital are being reallocated. Companies positioned to benefit from this trend could see substantial growth as the pivot accelerates.

Expert-Selected Opportunities

These aren't random energy stocks - they're carefully chosen companies that analysts believe are best positioned to capitalize on the gas pivot. From major producers to specialized service providers, each plays a key role in this transformation.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions